AU2003298920A1 - Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents - Google Patents
Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents Download PDFInfo
- Publication number
- AU2003298920A1 AU2003298920A1 AU2003298920A AU2003298920A AU2003298920A1 AU 2003298920 A1 AU2003298920 A1 AU 2003298920A1 AU 2003298920 A AU2003298920 A AU 2003298920A AU 2003298920 A AU2003298920 A AU 2003298920A AU 2003298920 A1 AU2003298920 A1 AU 2003298920A1
- Authority
- AU
- Australia
- Prior art keywords
- butyrylcholinesterase
- seq
- functional fragment
- acid sequence
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31066602A | 2002-12-04 | 2002-12-04 | |
| US10/310,666 | 2002-12-04 | ||
| PCT/US2003/038684 WO2004050041A2 (en) | 2002-12-04 | 2003-12-04 | Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003298920A1 true AU2003298920A1 (en) | 2004-06-23 |
Family
ID=32468084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003298920A Abandoned AU2003298920A1 (en) | 2002-12-04 | 2003-12-04 | Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080213281A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1581253A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006508665A (cg-RX-API-DMAC7.html) |
| CN (1) | CN100341568C (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003298920A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0316865A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2507626A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05005996A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004050041A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6989261B2 (en) * | 2001-12-20 | 2006-01-24 | Eli Lilly And Company | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| AR044388A1 (es) * | 2003-05-20 | 2005-09-07 | Applied Molecular Evolution | Moleculas de union a cd20 |
| EP2049661A4 (en) * | 2006-08-04 | 2012-07-04 | Pharmathene Inc | RECOMBINANT BUTYRYLCHOLINESTERASE WITH LONG HALF-LIFE |
| US20100009390A1 (en) * | 2008-05-09 | 2010-01-14 | The Regents Of The University Of California | Mutant antibodies with high affinity for egfr |
| US20100008978A1 (en) * | 2008-05-09 | 2010-01-14 | The Regents Of The University Of California | Nanoparticles effective for internalization into cells |
| WO2009139905A2 (en) * | 2008-05-16 | 2009-11-19 | Nektar Therapeutics | Conjugates of a cholinesterase moiety and a polymer |
| CA2784861A1 (en) | 2009-12-21 | 2011-07-14 | Pharmathene, Inc. | Recombinant butyrylcholinesterases and truncates thereof |
| CN103898101B (zh) * | 2012-12-27 | 2017-08-08 | 上海桀蒙生物技术有限公司 | 利用转基因动物乳腺生物平台大规模生产重组人丁酰胆碱酯酶的方法 |
| CN104630177A (zh) * | 2013-11-08 | 2015-05-20 | 中国农业大学 | 一种利用人丁酰胆碱酯酶迷你基因在乳腺中表达重组人丁酰胆碱脂酶的方法 |
| EP3719123A1 (en) | 2014-04-29 | 2020-10-07 | Mayo Foundation for Medical Education and Research | Uses of butyrylcholinesterase variants having an enhanced ability to hydrolyze acyl-ghrelin |
| WO2018053216A1 (en) * | 2016-09-15 | 2018-03-22 | Mayo Foundation For Medical Education And Research | Methods and materials for using butyrylcholinesterases to treat cancer |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1008049A1 (en) * | 1987-09-11 | 1999-04-30 | Whitehead Institute For Biomedical Research | Transduced fibroblasts and use therefor |
| US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5399346A (en) * | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5264563A (en) * | 1990-08-24 | 1993-11-23 | Ixsys Inc. | Process for synthesizing oligonucleotides with random codons |
| US5643578A (en) * | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
| US5620896A (en) * | 1992-03-23 | 1997-04-15 | University Of Massachusetts Medical Center | DNA vaccines against rotavirus infections |
| US5506125A (en) * | 1993-12-22 | 1996-04-09 | Agracetus, Inc. | Gene delivery instrument with replaceable cartridges |
| US5605793A (en) * | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5656465A (en) * | 1994-05-04 | 1997-08-12 | Therion Biologics Corporation | Methods of in vivo gene delivery |
| US6001625A (en) * | 1995-05-19 | 1999-12-14 | The United States Of America As Represented By The Secretary Of The Army | Site-directed mutagenesis of esterases |
| ATE317452T1 (de) * | 1998-06-16 | 2006-02-15 | Nova Molecular Inc | Verfahren zur behandlung von neurologischen erkrankungen mit hilfe der bestimmung des bche genotyps |
| CN1331339A (zh) * | 2000-06-26 | 2002-01-16 | 上海博德基因开发有限公司 | 一种新的多肽——人dna拓扑异构酶i11.44和编码这种多肽的多核苷酸 |
| AU2002248256B2 (en) * | 2000-12-26 | 2006-09-28 | Applied Molecular Evolution, Inc. | Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use |
| US20030153062A1 (en) * | 2001-12-20 | 2003-08-14 | Watkins Jeffry D. | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| US7070973B2 (en) * | 2000-12-26 | 2006-07-04 | Board Of Regents Of The University Of Nebraska | Butyrylcholinesterase variants and methods of use |
| US7049121B2 (en) * | 2001-12-20 | 2006-05-23 | Applied Molecular Evolution | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| US6989261B2 (en) * | 2001-12-20 | 2006-01-24 | Eli Lilly And Company | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
-
2003
- 2003-12-04 AU AU2003298920A patent/AU2003298920A1/en not_active Abandoned
- 2003-12-04 BR BR0316865-4A patent/BR0316865A/pt not_active IP Right Cessation
- 2003-12-04 CN CNB2003801050807A patent/CN100341568C/zh not_active Expired - Fee Related
- 2003-12-04 WO PCT/US2003/038684 patent/WO2004050041A2/en not_active Ceased
- 2003-12-04 CA CA002507626A patent/CA2507626A1/en not_active Abandoned
- 2003-12-04 MX MXPA05005996A patent/MXPA05005996A/es not_active Application Discontinuation
- 2003-12-04 JP JP2004557611A patent/JP2006508665A/ja active Pending
- 2003-12-04 US US10/535,441 patent/US20080213281A1/en not_active Abandoned
- 2003-12-04 EP EP03796682A patent/EP1581253A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20080213281A1 (en) | 2008-09-04 |
| CA2507626A1 (en) | 2004-06-17 |
| CN1720063A (zh) | 2006-01-11 |
| CN100341568C (zh) | 2007-10-10 |
| JP2006508665A (ja) | 2006-03-16 |
| WO2004050041A2 (en) | 2004-06-17 |
| MXPA05005996A (es) | 2006-04-18 |
| EP1581253A2 (en) | 2005-10-05 |
| EP1581253A4 (en) | 2007-02-14 |
| WO2004050041A3 (en) | 2004-10-28 |
| BR0316865A (pt) | 2005-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20050136044A1 (en) | Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents | |
| US20220378833A1 (en) | Dimerization switches and uses thereof | |
| RU2564125C2 (ru) | Мутеины липокалина 2 человека (lcn2, hngal) с аффинностью для определенной мишени | |
| JP2019115342A (ja) | IL−4Rαに結合する涙液リポカリンムテイン | |
| US20080213281A1 (en) | Butyrylcholinesterase Variants that Alter the Activity of Chemotherapeutic Agents | |
| US7070973B2 (en) | Butyrylcholinesterase variants and methods of use | |
| JP2001520016A (ja) | 低減されたリボヌクレアーゼインヒビターアフィニティーを有するヒトリボヌクレアーゼa | |
| JP2020530300A (ja) | 切断されたモルモットl−アスパラギナーゼバリアントおよび使用の方法 | |
| US6989261B2 (en) | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use | |
| KR102579284B1 (ko) | 신규의 cd47 바인더와 폴리뉴클레오티드를 포함하는 암 치료를 위한 리포좀 복합체 | |
| US7049121B2 (en) | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use | |
| WO2013020366A1 (zh) | 乙酰胆碱酯酶作为核酸酶的应用 | |
| JP4252311B2 (ja) | 増大した触媒効率を有するブチリルコリンエステラーゼポリペプチド改変体およびその使用方法 | |
| AU2002248256A1 (en) | Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use | |
| US20030153062A1 (en) | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use | |
| US8124393B2 (en) | Compositions and methods for inducing or inhibiting activities of selected human cells | |
| WO2023132380A1 (ko) | 5'-뉴클레오티다아제 변형 단백질을 암호화하는 암 치료를 위한 폴리뉴클레오티드 | |
| WO2022065724A1 (ko) | 암 치료를 위한 cd47 바인더 및 리포좀 복합체 | |
| US20150157696A1 (en) | Composition and method for inhibiting tumor cell growth | |
| WO2002030969A2 (en) | Regulation of human carboxylesterase-like enzyme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |